ABSTRACT
Importance Genomic footprints of pathogens shed by infected individuals can be traced in environmental samples, which can serve as a noninvasive method for infectious disease surveillance.
Objective To determine the efficacy of predicting COVID-19 cases using the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) found in air, surface swabs and wastewater samples.
Design A prospective experimental design utilizing randomized surveillance of air, surface, and wastewater samples was performed from March to May 2021. SARS-CoV-2 in environmental samples was concentrated with electronegative filtration and quantified using Volcano 2nd Generation-qPCR. Descriptive analyses were conducted to examine the associations between time-lagged SARS-CoV-2 in environmental samples and clinically diagnosed COVID-19 cases.
Setting This study was conducted in a residential dormitory at the University of Miami, Coral Gables campus.
Participants Random air and surface swab samples were collected in high-traffic areas of a college dormitory, housing roughly 500 students, with the number of individuals contributing at any point in time. Wastewater was collected from the dormitory where individuals from the resident population as well as any visitors of the building contributed to the sewer system. Students from the dormitory were randomly screened for COVID-19 for 2-3 days / week.
Main Outcome SARS-CoV-2 detection in environmental samples was an indicator of the presence of local COVID-19 cases and a 2-day lead indicator for a potential outbreak at the dormitory building scale. The hypothesis being tested was formulated prior to the data collection.
Results A total of 445 air, surface swab and wastewater samples were collected, and these data were aggregated by day. SARS-CoV-2 genomic footprints were detected in air, surface swab and wastewater samples on 52 (63.4%), 40 (50.0%) and 57 (68.6%) days, respectively, during the study period. On 19 (24%) of 78 days SARS-CoV-2 was detected in all three sample types. Clinically diagnosed COVID-19 cases were reported on 11 days during the study period and SARS-CoV-2 was also detected two days before the case diagnosis on all 11 (100%), 9 (81.8%) and 8 (72.7%) days in air, surface swab and wastewater samples, respectively.
Conclusion Proactive environmental surveillance of SARS-CoV-2 or other pathogens in a community/public setting has potential to guide targeted measures to contain and/or mitigate infectious disease outbreaks.
Question Could environmental surveillance provide a means of early detection for SARS-CoV-2 in high population communities, such as college campuses, or even cities?
Findings In this surveillance study, SARS-CoV-2 was detected from air, surface swab, and wastewater samples of a college dormitory in 165 (30%) of 445 total samples collected. When assessed alone, each sample type offered a means for predicting COVID-19 clinical cases (∼90%), however when aggregated, provided a prediction rate of roughly 100% for detecting SARS-CoV-2 within the community.
Meaning The findings suggest that the early detection of SARS-CoV-2 from environmental sampling including active air, surface swab, and wastewater surveillance provide an accurate and early means of detecting COVID-19 infection within high population communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institute of Health grant R01EY026174 (NK) National Institute of Health grant U01DA053941 (HS, SS, CM)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Miami Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All environmental data can be made available upon a reasonable request to the corresponding author. However, clinical data are confidential and cannot be shared with any one outside our team.
